Survivin -31G/C promoter polymorphism and sporadic colorectal cancer
- 23 October 2008
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 24 (2) , 145-150
Abstract
Introduction Survivin is an apoptotic inhibitor, plays an important role in cell cycle regulation, and may be involved in the development and progression of cancer. A common polymorphism at the survivin gene promoter (-31 G/C) has been shown to influence survivin expression and the risk for cancer. Aim The aim of the present study was to investigate whether this polymorphism could be involved in the sporadic colorectal cancer (CRC) development, prognosis, and survival. Materials and methods The -31G/C polymorphism of survivin promoter was analyzed by polymerase chain reaction (PCR) restriction fragment length polymorphism method in biopsies from 312 patients with sporadic CRC and 362 healthy individuals. Survivin messenger RNA (mRNA) expression in CRC tissues was detected by quantitative reverse transcriptase PCR. Results and discussion The genotype frequencies for -31GG, -31GC, and -31CC were 21.79%, 41.99%, and 36.22% in CRC patients and 33.98%, 45.03%, and 20.99% in healthy subjects, respectively. The frequencies of the survivin -31C allele and CC genotype were significantly higher in CRC patients than in healthy subjects (p < 0.0001). Homozygotes for the -31CC survivin genotype, expressed 1.6-fold higher mRNA levels of survivin compared to cases with the -31GG and -31GC genotypes. Conclusion The -31CC genotype of survivin promoter is associated with CRC and may be a risk factor for CRC.Keywords
This publication has 19 references indexed in Scilit:
- [Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma].2008
- The inhibitors of apoptosis: there is more to life than Bcl2Oncogene, 2003
- Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinomaGut, 2000
- Analysis of human transcriptomesNature Genetics, 1999
- Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.1999
- IAP family proteins---suppressors of apoptosisGenes & Development, 1999
- IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.1998
- Control of apoptosis and mitotic spindle checkpoint by survivinNature, 1998
- Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.1998
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995